melanoma
10 stories
-
healthMEL-SELF Trial Reveals Confidence Gaps in Melanoma Self-Examination
New baseline data from Australia's MEL-SELF trial shows 20% of melanoma survivors hadn't performed skin self-exams in a year-and 46% reported clinically significant fear of cancer recurrence.
-
healthNew Immune Markers Could Predict Melanoma Aggression and Treatment Response
Scientists identify three immune-related genes, LAG-3, TIGIT, and HAVCR2, that may predict melanoma progression and patient response to immunotherapy.